Subscribe Now
Forward to a Friend

DID YOU KNOW...

That 21 CFR Part 11 has a retention requirement for audit trail documentation?
Full Story


Especially for Pharmaceuticals

The difference between getting your NDA or BLA approved by the FDA during the first cycle of product review and getting it approved much later may very well lie in how early and how effective you communicate with the agency. Full Story

Additional Articles:
Especially for Pharmaceuticals



Especially for Medical Devices

Wouldn't it be great to launch a product globally? It certainly makes good business sense. But for medical device firms, it's an unreasonable goal because different countries require different submission formats.
By Matthew M. Lowe
Full Story

Additional Articles:
Especially for Medical Devices



Especially for Blood / Biologics

After the FDA shut down two tissue-recovery firms last year because of serious GTP violations, the agency issued a guidance reminding the industry to comply with the regulation.
Full Story

Additional Articles:
Especially for Blood / Biologics



How to Solve the Top Five Training Management Challenges

A Warning Letter sent by the FDA in February to Medical Concepts Development, a Minnesota medical device company, listed eight CGMP violations. Two of the infractions were related to training management: failure to document employee training and failure to establish procedures for identifying training needs.

Why is training important to life science companies? The FDA states it clearly in the Quality System Regulation (QSR) Manual, which says: “Quality is the responsibility of every employee — any employee can generate a quality problem through ignorance of their job requirements or negligence.”

It is imperative for life science employees to have the proper education and training for their jobs. Moreover, the FDA expects employers to provide continuous personnel training to make sure employees can effectively perform their jobs. Ongoing training is what makes training management critical; it is the area where many life science companies stumble. Here are five common challenges faced by life science companies and some possible solutions.
Read more.



FDA Listens to Public Input on Electronic Submission
By Lane Hirning

The FDA wants to eventually move to an all-electronic regulatory submission environment. The question is, how?

Representatives of 26 companies and organizations presented their views and six others made public comments at the FDA's public hearing on the viability of a paperless regulatory submission process.

"Let me stress this is a listening exercise for FDA," said Dr. Janet Woodcock, deputy commissioner for operations of the Food and Drug Administration, at the meeting held on Dec. 18, 2006. The public hearing discussed feasibility issues pertaining to electronic pre-market submissions and issues related to the concept of an electronic platform for the exchange of clinical research information and other regulatory product information.

Over the last decade, the FDA has transformed some aspects of regulatory reporting from paper to electronic means, but the adoption has been voluntary. The FDA has also been collaborating with manufacturers, standard development organizations, and other government agencies to develop data standards and build databases for sharing certain clinical trial information.
Read more.

Upcoming Events

Check out conferences, trade shows, and other events for life science professionals.

Register for your free
exhibit Hall Pass to INTERPHEX
(April 24-26, 2007)

MasterControl Road Show
"Industry Experts Discuss How EU Compliance Can Be Made Simple"
(April 30 - May 3, 2007)

View the entire list


Editorial Staff

Know the difference between IDE and IND? Between a 483 and a Warning Letter? How about GMP versus GTP?
Read more.


Editorial Staff

We Want Your Feature Articles


GxP Lifeline welcomes articles that are informative, interesting, and useful to life science professionals.
Read more.


Editorial Staff

GxP Lifeline
is published once a month by MasterControl Inc.
6322 S. 3000 E., Suite 110
Salt Lake City, UT 84121
.
Web site: www.mastercontrol.com

Publisher: Curt Porritt
Executive Editor: Jason Clegg
Editor: Cindy Fazzi
Design: Mike Hansen
About Us

If you have any comments about the content of this newsletter, send it to
Cindy Fazzi.


Visit mastercontrol.com